Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

IDEX Health & Science Launches Innovative Avant™ Optical Filter Set Family


News Image

“The developments made with our Avant Filters marks the first significant breakthrough in optical filter technology in years, which will have a lasting impact on the life science industry,” said Xavier El Baz, Sr. Product Manager.

IDEX Health & Science has extended its line of Semrock™ brand optical filters with the launch of the new Avant™ filter set family. This new filter set has been designed to provide significant improvement in fluorescence performance for corresponding short Stokes Shift fluorophores.

“The developments made with our Avant Filtersnull marks the first significant breakthrough in optical filter technology in years, which will have a lasting impact on the life science industry,” said Xavier El Baz, Sr. Product Manager.

While every fluorescent filter set has a Gap separating excitation and emission passbands, many sets for short Stokes Shift probes have large Gaps that shift the emission filter to longer wavelengths. The emission filter captures less fluorescence and the filter set’s performance is therefore reduced. Until now, limitations in the coating process and excessive bleed-through into the emission channel have resulted in lower-performing filter sets that impact many fluorescence systems today.

IDEX Health & Science’s new Semrock Avant technology narrows this Gap and brings the emission and excitation passbands close together. The Avant family of sets thereby deliver significant increases in fluorescence signal. This is achieved with steep spectral edges and high OD blocking of the excitation passband in the emission filter. The spectral features are confirmed by Semrock’s high-resolution KolaDeep™ Spectral Measurement System, and the new Precise Edge Placement capability assures that every filter set delivers consistent performance.

Learn More About Maximizing Fluorescence Performance with Avant

About IDEX Health & Science, LLC

IDEX Health & Science, LLC is the global leader in life science fluidics, microfluidics, and optics, offering a three-fold advantage to customers by bringing optofluidic paths to life with strategic partnerships, solutions, and expertise. As one of the few companies in the world with component, sub-system, and application level experts, IDEX Health & Science helps instrument developers solve the most demanding fluidic and optical challenges in a wide array of applications. At IDEX Health & Science we believe partnership will change the way the world innovates, leading to new technologies that improve our health, protect our planet, and enrich our lives. For more information visit: http://www.idex-hs.com

Share article on social media or email:

Scientist.com Wins 2022 BioTech Breakthrough Award for “Overall BioPharma Solution of the Year”


News Image

“We are thrilled to be a 2022 BioTech Breakthrough award winner. By eliminating paperwork and bureaucracy and creating a more automated and intelligent R&D process, Scientist.com is helping drive tomorrow’s great discoveries, today.”— Chris Petersen, Founder and CTO at Scientist.com.

Scientist.com, the biopharma industry’s leading R&D platform, announced it has been recognized as “Overall BioPharma Solution of the Year” in the second annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe. Scientist.com is the world’s largest platform for outsourced R&D, connecting global research organizations with contract research organizations (CROs) and enabling decentralized R&D. The custom-built, cloud native platform offers hundreds of custom configurations and integrates deeply within client procurement, compliance and finance systems. This unique platform architecture allows for implementation in days.

“We are thrilled to be a 2022 BioTech Breakthrough award winner,” said Chris Petersen, Founder and CTO at Scientist.com. “By eliminating paperwork and bureaucracy and creating a more automated and intelligent R&D process, Scientist.com is helping drive tomorrow’s great discoveries, today.”

Scientist.com enables researchers to ‘do more with less’ by saving time, reducing costs, improving access to innovation and ensuring compliance with internal and external regulations. Researchers using Scientist.com have instant access to the world’s largest laboratory network, including over 4,000 CROs and academic labs, which offer tens of thousands of innovative tools, technologies and lab supplies.

“Scientist.com was chosen among numerous applicants for providing a solution to some of the biggest problems facing research organizations today, including a decline in R&D efficiency and the rising cost of bringing new products to market,” said Bryan Vaughn, Managing Director of BioTech Breakthrough Awards. “The Scientist.com platform allows researchers to focus their attention on carrying out game-changing R&D that can dramatically improve research success. Congratulations to them for being our choice for ‘Overall BioPharma Solution of the Year.’”

The mission of the annual BioTech Breakthrough Awards program is to conduct the industry’s most comprehensive analysis and evaluation of the top companies, solutions and products in the life sciences and biotechnology industry today. This year’s program attracted more than 1,350 nominations from over 12 different countries throughout the world. A full list of 2022 BioTech Breakthrough Awards winners can be found at https://biotechbreakthroughawards.com/2022-winners/

About Scientist.com

Scientist.com’s mission is to empower and connect scientists worldwide. Our digital research platform combines sophisticated AI technology with white-glove Research Concierge support to enable scientists to run more innovative experiments in less time and at lower cost. Scientist.com operates private “business to enterprise” marketplaces for most of the world’s major pharmaceutical companies, over 100 biotechnology companies, and the US National Institutes of Health (NIH).

Join Scientist.com on social media: YouTube, LinkedIn, Twitter, Facebook and Instagram.

About BioTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughawards.com

Share article on social media or email:



Amerisure Earns Metropolitan Detroit’s Best and Brightest Companies to Work For® Recognition


“The Metro Detroit Best and Brightest award is a testament to the efforts of our employees and leadership, as well as our ability to deliver on our One Amerisure service model,” said Erin Buddie, vice president of human resources at Amerisure.

Amerisure Insurance Company has once again been recognized among the Metropolitan Detroit Best and Brightest Companies to Work For®. This year marks the 17th time Amerisure has been named to the prestigious list for Southeastern Michigan.

Participating organizations were evaluated and assessed based on categories such as communication, work-life balance, employee education, diversity, recognition and retention. The winning companies display “a commitment to excellence in their human resource practices and employee enrichment.”

“Amerisure succeeds as an organization due to the valuable contributions of our talented employees, and we’re proud to be recognized for our culture of collaboration and high levels of employee engagement,” said Erin Buddie, vice president of human resources at Amerisure. “The Metro Detroit Best and Brightest award is a testament to the efforts of our employees and leadership, as well as our ability to deliver on our One Amerisure service model.”

The Best and Brightest Companies to Work For® program is sponsored by The National Association for Business Resources (NABR) and celebrates organizations cultivating better business, creating richer lives and building stronger communities. Recipients of the annual Metro Detroit award will be recognized at a virtual celebration on November 9.

To see the full list of 2022 Metro Detroit recipients, click here.

In addition to the Best and Brightest Companies to Work For® in Metro Detroit award, Amerisure has also been named among the 2022 Best and Brightest Companies to Work For® in Atlanta and in the Nation and was recognized by Insurance Journal as a 2022 Super Regional Property/Casualty Insurer™.

About Amerisure Insurance

Amerisure is a leading provider of commercial property and casualty insurance solutions for U.S.-based construction, manufacturing and healthcare businesses. Licensed in all fifty states and available through an exclusive network of elite independent agents, the company upholds an “A” (Excellent) financial strength rating, industry-leading service scores, and multiple awards for innovation. Amerisure has been in business for more than 100 years and is consistently named among the best places to work in the industry and throughout the nation. To learn more, visit Amerisure.com.

Share article on social media or email:

Patient Experience Journal, in Association with The Beryl Institute, Releases Volume 9, Issue 3


The Beryl Institute announces the publication of Volume 9, Issue 3 of Patient Experience Journal (PXJ), an international, open access, peer-reviewed journal focused on research and proven practices related to understanding and improving the patient experience. Read in over 220 countries and territories, PXJ articles have been downloaded over one million times and reflects the journal’s commitment to disseminating rigorous knowledge and expanding the global conversation on evidence and innovation in patient and human experience.

Published in association with The Beryl Institute, Volume 9, Issue 3 includes 25 articles representing commentaries, personal narratives, research studies and case studies covering topics such as:

  • Living with brain cancer: From researcher to patient
  • The intersection of diversity, equity and inclusion with pediatric Patient and Family Advisory Councils
  • Patient experience of Electronic Health Records (EHR) in a maternity unit in Ireland
  • Going from academic medical center to a community hospital: Patient experiences with transfers
  • Home health care CAHPS® survey: Predicting patient experience performance
  • A patient perspective on information provision during the care path of Lentigo Maligna
  • Technology about me without me: An examination of the relationship between patient-facing technology and patient experience

The research represents a broad range of global organizations and institutions including Ann & Robert H. Lurie Children’s Hospital of Chicago, Cincinnati Children’s Hospital Medical Center, Deakin University Geelong. School of Nursing & Midwifery, Institute for Health Transformation, Centre for Quality & Patient Safety Research, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands, Experience of Care Lead, NHS England and NHS Improvement, Florida State University College of Medicine, George Washington University Health.Links, Saudi Arabia, Katholieke Universiteit Leuven, Mayo Clinic, McMaster University, Medallia, QEII Jubilee Hospital, Royal Manchester Children’s Hospital, Sentara Healthcare, University College Cork, University of Alabama-Birmingham, University of California San Francisco, University of Oxford, University of Port Harcourt, University of Twente.

“As was known even prior to the pressures placed on us by the pandemic, what lied just beneath the surface of our work in healthcare was clear,” said Jason Wolf, Founding Editor of PXJ and President & CEO of The Beryl Institute. “…But amid this turbulent reality, I believe there is hope, a space for optimism and a solid foundation on which we can and must build. It is this commitment to action and a contribution to the larger conversation that we continue to see reflected on the pages of PXJ itself. In our final issue of 2022 and the close of Volume 9, we release one of our largest issues ever. We continue to hear from the voices of patients and care partners, clinicians and researchers, all committed to elevating the evidence and practice driving the healthcare experience.”

To access Volume 9, Issue 3 of PXJ, visit:http://pxjournal.org/journal

###

About Patient Experience Journal:

Patient Experience Journal (PXJ) is a peer-reviewed, open-access journal published in association with The Beryl Institute. Read in over 220 countries and territories, PXJ is committed to disseminating rigorous knowledge and expanding the global conversation on evidence and innovation on patient experience.

About The Beryl Institute:

The Beryl Institute is a global community of professionals and experience champions committed to transforming the human experience in healthcare. As a pioneer and leader of the experience movement and patient experience profession for more than a decade, the Institute offers unparalleled access to unbiased research and proven practices, networking and professional development opportunities and a safe, neutral space to exchange ideas and learn from others.

We define the patient experience as the sum of all interactions, shaped by an organization’s culture, that influence patient perceptions across the continuum of care. We believe human experience is grounded in the experiences of patients & families, members of the healthcare workforce and the communities they serve.

Share article on social media or email:

Amerisure Named Among the Best and Brightest Companies to Work For® in the Nation


“It’s an honor to receive the Best & Brightest award at the national level and be recognized for a commitment to our exceptional team,” said Erin Buddie, vice president of human resources at Amerisure.

Amerisure Insurance Company is proud to be recognized as a 2022 winner in the annual Best and Brightest Companies to Work For® in the Nation program. This year marks the seventh time Amerisure has been named to the prestigious national list.

Amerisure was assessed and named among the winning companies for displaying “a commitment to excellence in their human resource practices and employee enrichment.” Participating companies were evaluated by an independent research firm on categories such as communication, work-life balance, employee education, diversity and inclusion, recognition and retention.

“Our expert employees are Amerisure’s greatest strength and asset; to be awarded for our engagement and enrichment efforts is a testament to the strength of our collaborative One Amerisure service culture,” said Erin Buddie, vice president of human resources at Amerisure. “It’s an honor to receive the Best & Brightest award at the national level and be recognized for a commitment to our exceptional team.”

The Best & Brightest program is sponsored by The National Association for Business Resources (NABR). Winners will be recognized for their achievements during a virtual awards ceremony on Nov. 7, 2022.

To see the full list of 2022 Best and Brightest Companies to Work For® recipients, click here.

In addition to the Best and Brightest Companies to Work For® in the Nation award, Amerisure has also been named among Metro Detroit and Atlanta’s 2022 Best and Brightest Companies to Work For® and was recognized by Insurance Journal as a 2022 Super Regional Property/Casualty Insurer™.

About Amerisure Insurance

Amerisure is a leading provider of commercial property and casualty insurance solutions for U.S.-based construction, manufacturing and healthcare businesses. Licensed in all fifty states and available through an exclusive network of elite independent agents, the company upholds an “A” (Excellent) financial strength rating, industry-leading service scores, and multiple awards for innovation. Amerisure has been in business for more than 100 years and is consistently named among the best places to work in the industry and throughout the nation. To learn more, visit Amerisure.com.

Share article on social media or email:

OSPITEK and PRO-MAPP Announce Strategic Partnership; Combining Live Patient Pathway Visualization, Automated Dictation Free OR Reporting, and Enterprise Intelligence


“Combining these efficiencies between platforms is a true win for the customer and we are very excited to introduce the combined product.” Bill Hartman, CEO, PRO-MAPP

The strategic partnership between OSPITEK and PRO-MAPP combines, IoT enabled, live ASC visualization and communication tools with instant OR reports that are prepared for same-day billing with zero dictation. The efficiency of outpatient surgery centers will be immediately improved by this combined offering, which will maximize patient throughput, accelerate ASC revenue generation, and support the provision of an excellent patient experience.

Hospitals and ASCs must continuously assess the efficiency of their operating rooms and related resources. Efficiency considerations include avoidance of delayed case start times, operating room turnover, management of reported complications, staff, patient and care-taker communication, block scheduling, and more. Deficiencies in any of these areas negatively impact the profitability of ASCs and the overall ASC experience for patients.

To ensure a positive day of surgery experience, and the effective use of OR resources, ASCs need to be able to access detailed and accurate operating room and day-of-surgery performance metrics, easily produce required reporting, and instantly communicate critical information to all stakeholders leading up to, on, and after the day of surgery.

Without the right technology it can be challenging to coordinate all the factors for sustained efficiency; this is where the robust reporting, communication and care coordination capabilities of OSPITEK and PRO-MAPP come in.

The OSPITEK and PRO-MAPP platforms perfectly compliment each other and empower a, first of it’s kind, comprehensive ASC management and digital coordination experience. The combined offering leverages cutting edge technology to streamline adoption, ASC efficiency, and most importantly support best-in-class patient experiences.

With live, fully interoperable, cross-platform visualization and communication tools, OSPITEK’s proprietary platform, VIEW, enables the adoption of IoT (Internet of Things) and AI into the daily workflows of outpatient surgery centers and hospitals. Delivering live visualization, the VIEW platform aligns workflows across the entire patient pathway using a modular design, which keeps care teams on the same page, maximizes workflow efficiency, removes barriers to real-time communication, and enhances the patient, staff, and family member experience.

PRO-MAPP further streamlines efficiencies with the platform’s unique ability to produce signed and coded operative reports immediately upon completion of the surgical procedure with zero dictation from the surgeon; a process that saves time, reduces staff burden, and readies the practice to bill for those services on the same day of surgery.

PRO-MAPP’s CEO Bill Hartman had this to say about the partnership:

“For ASC’s to be successful in today’s market, efficiency has to be the premium. Efficiency is at the core of the OSPITEK platform and the information collected is used in a variety of value creating outputs. PRO-MAPP embraces this same philosophy and happens to have a very unique platform focused on surgical and device data combined with patient outcomes, something no one else is collecting at this level of detail. Combining these efficiencies between platforms is a true win for the customer and we are very excited to introduce the combined product.”

With this combined offering, ASC’s will be able to immediately improve the patient experience, save time and increase revenue.

About OSPITEK:

Interoperable with legacy systems for seamless adoption, OSPITEK’s VIEW platform empowers ASC’s with IoT and AI enabled live visualization, patient communication, and workflow management tools. The VIEW platform’s modular software suite support surgeons and ASC’s from the moment a patient is scheduled for a procedure, with support extending beyond the day-of-surgery. Driven by the patient’s physical movement, the VIEW platform delivers real-time status updates to care-teams and care-takers via a fully digitized, cross platform, visualization experience.

About PRO-MAPP:

PRO-MAPP is an outcomes measures data platform that outputs engineered data reducing pain points for surgeon and practice. PRO-MAPP’s experienced team will tailor the platform to your practice and surgical needs. Our high quality outcomes measures, automatic operative reporting, and enhanced revenue generating system will drive value, increase efficiency, save time, and increase revenue for you.

Share article on social media or email:

Washingtonian recognizes 15 Shady Grove Fertility (SGF) physicians as 2022 Top Doctors for infertility


News Image

“Having 15 SGF physicians recognized by their peers and the Washingtonian is an honor that highlights our dedication to delivering patient-centered, individualized fertility care.”

Shady Grove Fertility (SGF) proudly announces that 15 of the practice’s physicians from the Washington, D.C., metro region have been named 2022 Top Doctors for infertility by Washingtonian. Nearly 3,000 regional physicians participated in Washingtonian’s survey, ultimately nominating 1,900 colleagues in each of the represented 40 specialties. Washingtonian’s Top Doctors list is referred to as “the region’s very best,” and is intended to help readers find the best medical care in their communities.

“As leaders in the field of reproductive medicine, the SGF physician team is committed to practice innovative, evidence-based medicine,” shares Eric. A. Widra, M.D. “Having 15 SGF physicians recognized by their peers and the Washingtonian is an honor that highlights our dedication to delivering patient-centered, individualized fertility care.”

SGF’s reproductive endocrinologists (REI) honored in the Washingtonian include:

Paulette E. Browne, M.D.

Joseph Doyle, M.D.

Kate Devine, M.D.

Naveed M. Khan, M.D.    

Eric Levens, M.D.    

Michael J. Levy, M.D.    

Shruti Malik, M.D.

Kimberly S. Moon, M.D.

Anitha S. Nair, M.D.

Jeanne E. O’Brien, M.D.

Barbara H. Osborn, M.D.

Andrea E. Reh, M.D.    

Arthur W. Sagoskin, M.D.    

Eric A. Widra, M.D.

SGF’s reproductive urologist honored in the Washingtonian include:

Paul R. Shin, M.D.

“We thank our patients, peers, and the Washingtonian for their recognition and the trust they place in us,” shares Dr. Malik, who provides patient care at SGF’s Arlington, Virginia, location. “Every day, I feel privileged to be a part of a team like Shady Grove Fertility where we are all committed to supporting the needs of our patients, and most importantly, helping them to fulfill their dream of parenthood.”

For people struggling to conceive, it may be time to consult a fertility specialist. Contact the SGF New Patient Center at 1-888-761-1967 or complete a brief online request form to schedule an in-person or virtual consult with an SGF physician. A physician consult is the first step toward pursuing a pregnancy with the help of SGF.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With 50 locations, including the newest location in Raleigh, North Carolina, as well as throughout CO, FL, GA, MD, NY, PA, TX, VA, D.C., and Santiago, Chile, SGF offers patients in-person and virtual physician consults, delivers individualized care, accepts most insurance plans, and makes treatment affordable through innovative financial options, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-led partnership of top-tier fertility practices in the U.S. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Share article on social media or email:

US Fertility hosts Fall Fertility Week featuring 8 free events for the 1 in 8 experiencing infertility


Join US Fertility physicians for Fall Fertility week.

“Fall Fertility Week is intended to build a sense of community for those facing the challenges posed by infertility. The events provide attendees with the information they need to confidently pursue their family-building goals.”

US Fertility partner practices proudly host Fall Fertility Week from November 7-11, 2022, complete with 8 free, virtual patient education events. Over the course of 5 days, US Fertility physicians will host webinars and Instagram Live sessions featuring topics like fertility treatments, menstrual cycles, fertility health, endometriosis, polycystic ovary syndrome (PCOS), and LGBTQ+ family-building, among others. Each event concludes with a live question-and-answer session where attendees will have the opportunity to have their questions answered live by US Fertility physicians.

“It can feel daunting to manage fertility testing and treatments. There is strength in knowing that you are not alone; 1 in 8 people is faced with infertility,” shares Caleb Kallen, M.D. Ph.D., who sees patients at SGF’s Philadelphia, Pennsylvania, location, and who will host the in vitro fertilization (IVF) webinar on November 11 at 12 p.m. EST. “Fall Fertility Week is intended to build a sense of community for those facing the challenges posed by infertility. The events provide attendees with the information they need to confidently pursue their family-building goals.”    

US Fertility is the largest network of physician-owned and physician-led fertility practices in the nation. With more than 130,000 babies born to its credit, US Fertility completes more than 30,000 fresh IVF cycles annually, nearly 70,000 cycles total, including frozen embryo transfers, and performs 1,000+ elective and donor egg freezing cycles annually. US Fertility partner practices include Fertility Centers of Illinois (FCI), IVF FLORIDA, Reproductive Science Center of the San Francisco Bay Area (RSC), and Shady Grove Fertility (SGF).

Interested attendees are welcome to join as many Fall Fertility Week events as they desire, even if they cannot attend the live presentation. All registrants will receive a recording of each event via email to view at their convenience.

Fall Fertility Week 2022 events at-a-glance

Monday, November 7, 2022 @ 1 p.m. EST| Fertility Health Instagram Live | Allison Rogers, M.D., FCI physician

Tuesday, November 8, 2022 @ 12 p.m. EST | Fertility 101 Webinar and Q&A | Valerie Libby, M.D. M.P.H., SGF physician

Tuesday November 8, 2022 @ 4 p.m. EST | Egg Freezing Instagram Live | Channing Burks Chatmon, M.D., FCI physician

Wednesday, November 9, 2022 @ 3 p.m. EST | Menstrual Cycle Webinar and Q&A | Quinton Katler, M.D., M.Sc., SGF physician

Thursday, November 10, 2022 @ 3 p.m. EST | PCOS Webinar and Q&A | Evan Rosenbluth, M.D., RSC physician

Thursday, November 10, 2022 @ 5 p.m. EST | LGBTQ+ Family Building Instagram Live | Eduardo Hariton, RSC physician

Friday November 11, 2022 @ 12 p.m. EST| IVF Webinar and Q&A | Caleb Kallen, M.D., Ph.D., SGF physician

Friday, November 11, 2022 @ p.m. EST | Endometriosis Instagram Live | Daniel R. Christie, M.D., IVF FLORIDA physician

While US Fertility webinars are complimentary, interested parties must register to attend by visiting the calendar of events.

About US Fertility 

US Fertility is the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices, offering comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase patient access. To learn more about partnership- or affiliate-status benefits, call 301-545-1308 or visit USFertility.com. 

Share article on social media or email:



New Study Finds Higher Prevalence of Age-Related Macular Degeneration (AMD) Cases than Previously Determined and a High Degree of County Variation


New study shows higher prevalence of Age-related Macular Degeneration (AMD) cases in the United States than previously determined.

“AMD is a major cause of vision impairment and blindness, and costs Medicare approximately $1,290 per beneficiary diagnosed,” said David B. Rein, Ph.D., Program Area Director for NORC at the University of Chicago’s Public Health Analytics Program and the lead author of the study.

A new study “The Prevalence of Age-Related Macular Degeneration in the United States In 2019” published in JAMA Ophthalmology, found that in 2019, there were an estimated 19.83 million Americans were living with some form of age-related macular degeneration (AMD) in 2019. This is an increase of approximately more than 2.75 times previous estimates (which used a more conservative definition of early AMD based on larger drusen size). An estimated 18.34 million Americans had early AMD and 1.49 million had the late-stage vision threatening form of AMD (“late AMD” included choroidal neovascularization and geographic atrophy). In addition to national prevalence data, the new study also provides data by state and by county.

AMD is a leading cause of vision loss for Americans ages 50 and older. AMD prevalence has not been estimated for the United States in over a decade and early AMD prevalence estimates are scarce and have been inconsistently measured. The new study was authored by researchers from NORC at the University of Chicago (NORC), the Institute for Health Metrics and Evaluation (IHME) at the University of Washington (Seattle), The Department of Ophthalmology and Visual Sciences, University of Michigan, the Institute for Social Research, University of Michigan, and the Centers for Disease Control and Prevention’s (CDC) Vision Health Initiative, with support from Prevent Blindness.

“AMD is a major cause of vision impairment and blindness, and costs Medicare approximately $1,290 per beneficiary diagnosed,” said David B. Rein, Ph.D., Program Area Director for NORC at the University of Chicago’s Public Health Analytics Program and the lead author of the study. “We developed estimates at the national, state, and county level with an interest in helping local officials understand their area’s disease burden of AMD.”

Additional key findings from the study include:

  • Approximately one in 10 Americans ages 50 and older have the early form of AMD and approximately 1 out of every 100 Americans ages 50 and older have the vision threatening late form.
  • Among persons ages 80 and older, approximately 3 in 10 had early AMD, and approximately 1 and 10 have the vision threatening late form.
  • Gender, and age-standardized rates of the disease were lowest for Black Americans as compared to other race/ethnicity groups.
  • The prevalence of both early and late AMD varied widely by U.S. County. After standardizing by gender and race/ethnicity, rates for vision threatening AMD were the highest in the Midwest and New England regions of the country, and in Florida.


“Age-related macular degeneration is a leading cause of vision loss in older adults. With the aging of the U.S. population, there may be an increased burden of this condition on the functioning and independence of older adults,” said CDC epidemiologist Elizabeth Lundeen, PhD, MPH. “Providing updated data on the distribution of AMD across U.S. states and counties, this first analysis of its kind, can aid in the prioritization and planning of public health interventions to mitigate the disability-related consequences of this common eye disease.”

Study estimates were developed using data within CDC’s Vision and Eye Health Surveillance System (VEHSS). The VEHSS houses diverse data sources for vision – including Medicare, Medicaid, and private insurance claims data, electronic health record data, and self-reported and clinical evaluation data from representative national surveys. Researchers used a statistical methodology called Bayesian meta-regression which used the system’s multiple data sources to produce new, more comprehensive national and state-level estimates of vision loss and blindness.

“This granular level of detail on AMD cases across the country helps medical communities and decision makers gain a better understanding of where the greatest need is for treatment, public health outreach, and resources,” said Abraham D. Flaxman, Ph.D., Associate Professor of Health Metrics Sciences (IMHE) at the University of Washington’s School of Medicine, and study co-author. “Our hope is that this new data will ultimately improve population health at the local, state, and national level.”

Prevent Blindness serves as an engagement and communication channel for the VEHSS, working directly with NORC, CDC, and other partners. For AMD patients and their caregivers, Prevent Blindness offers the redesigned Living Well with Low Vision resource, with a variety of free directories, library of self-help guides, downloadable apps, and news interest for people living with AMD and significant visual impairment.

For more information on the “The Prevalence of Age-Related Macular Degeneration in the United States In 2019” study or the VEHSS, visit https://www.cdc.gov/visionhealth/vehss/. Or visit the Prevent Blindness page at https://preventblindness.org/amd-prevalence-vehss.

For information on AMD, please visit https://www.cdc.gov/visionhealth/resources/features/macular-degeneration.html or https://preventblindness.org/amd-age-related-macular-degeneration/.

About NORC at the University of Chicago

NORC at the University of Chicago conducts research and analysis that decision-makers trust. As a nonpartisan research organization and a pioneer in measuring and understanding the world, we have studied almost every aspect of the human experience and every major news event for more than eight decades. Today, we partner with government, corporate, and nonprofit clients around the world to provide the objectivity and expertise necessary to inform the critical decisions facing society.

http://www.norc.org

About the Institute for Health Metrics and Evaluation

The Institute for Health Metrics and Evaluation (IHME) is an independent global health research organization at the University of Washington School of Medicine that provides rigorous and comparable measurement of the world’s most important health problems and evaluates the strategies used to address them. IHME is committed to transparency and makes this information widely available so that policymakers have the evidence they need to make informed decisions on allocating resources to improve population health.

About University of Michigan

The University of Michigan is recognized as a leading university globally across disciplines. It ranks second among U.S. public institutions and in the top 10 overall as a recipient of NIH research funds. The Department of Ophthalmology and Visual Sciences is one of the top ranked departments in the country for both NIH funding and clinical care. With over $80 million annually in funded awards, the Institute for Social Research (ISR), is the world’s largest academic social science survey and research organization, a leader in developing and applying new social science methods, and committed to educating the next generation of social scientists.

About the Vision Health Initiative

CDC’s Vision Health Initiative (VHI) works to improve vision health in the U.S. through collaborations with state and national partners to strengthen science and develop interventions that promote eye health and prevent vision loss and blindness in groups at high risk. VHI also seeks to address risk factors like glaucoma, reduce disparities in vision loss and eye disease, and improve health and quality of life for people with vision loss. VHI designs and implements public health surveillance at the state and national level, supports applied public health research, and promotes the dissemination of evidence-based vision health interventions. In collaboration with state and community partners, VHI works to integrate vision health activities into broader public health strategies and interventions. For more information, visit http://www.cdc.gov/visionhealth.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at preventblindness.org, and follow us on Facebook, Twitter, Instagram, LinkedIn and YouTube.

###

Share article on social media or email:

Steve and Michel Gleason Named 2022 Recipients of ASHA’s Prestigious Annie Glenn Award


“Steve and Michel personify resilience and, like ASHA members, they, through their leadership of Team Gleason’s incredible work, have helped many live their lives to the fullest.”

Steve and Michel Gleason will receive the American Speech-Language-Hearing Association’s (ASHA) most prestigious public honor, the Annie Glenn Award, at the ASHA Convention in New Orleans this November.

After Steve was diagnosed with amyotrophic lateral sclerosis (ALS) in 2011, the Gleasons created the Team Gleason Foundation, which provides equipment, technology, services, care, and life-changing adventures for people living with the disease.

Prior to his diagnosis, Steve played football for the New Orleans Saints and blocked a punt the night the New Orleans Superdome reopened after Hurricane Katrina. The feat was widely celebrated as a rallying point for the city, which was recovering from the storm. Upon receiving his ALS diagnosis, Steve vowed there would be “no white flags,” refusing to give up on himself, his family, or others living with ALS. “No white flags” eventually became the rallying cry for many—including Team Gleason.

“Reframe your Thinking: Resilience Reinvented is the theme of ASHA Convention this year,” said ASHA President Judy Rich, EdD, CCC-SLP, BCS-CL. “Steve and Michel personify resilience and, like ASHA members, they, through their leadership of Team Gleason’s incredible work, have helped many live their lives to the fullest.”

The impact of the Gleasons’ advocacy extends to Capitol Hill. In 2015, Congress passed the Steve Gleason Act, which ensures access to assistive communication devices for all people who need them, and subsequent legislation made the devices eligible for Medicaid and Medicare reimbursement. In 2020, Steve received the U.S. Congressional Gold Medal, the nation’s highest civilian honor, for his advocacy and being a source of hope and inspiration for many.

Named for Annie Glenn, ASHA’s Annie Award honors those who have made a positive impact on the lives of people with communication disorders. Mrs. Glenn, who experienced a severe stutter well into her adult years, was a lifelong champion for people with speech, language, and hearing disorders.

Past recipients of the Annie Glenn Award include former U.S. Congresswoman Gabby Giffords and U.S. Senator and retired astronaut Mark Kelly; “Miracle on the Hudson” pilot Captain Sully Sullenberger; and President Joe Biden.

About the American Speech-Language-Hearing Association (ASHA)

ASHA is the national professional, scientific, and credentialing association for 223,000 members and affiliates who are audiologists; speech-language pathologists; speech, language, and hearing scientists; audiology and speech-language pathology support personnel; and students. Audiologists specialize in preventing and assessing hearing and balance disorders as well as providing audiologic treatment, including hearing aids. Speech-language pathologists (SLPs) identify, assess, and treat speech, language, and swallowing disorders. http://www.asha.org

View all ASHA press releases at https://www.asha.org/about/press-room/.

Share article on social media or email: